Latest News

HWL Ebsworth acts for McWilliams Wines Group on recapitalisation transaction with Margaret River Wine Production and Laguna Bay

HWL Ebsworth has advised McWilliam’s Wines Group on its recapitalisation transaction with Margaret River Wine Production (MRWP) and agricultural fund manager, Laguna Bay. The recapitalisation transaction involved debt and equity investments by Laguna Bay into MRWP and the issue by McWilliams of convertible notes to MRWP. The funds will be used by McWilliams primarily for … Read more


HWL Ebsworth helps write the script for global athlete media merger

HWL Ebsworth has advised Unscriptd on its sale to The Players Tribune, Inc (TPT). The transaction completed on 30 November 2018 with Unscriptd receiving an undisclosed percentage of the share capital in TPT. Unscriptd is a leading global athlete media & technology business that was founded in 2014. Unscriptd enables athletes to be better publishers … Read more


HWL Ebsworth advises on the IPO of 1414 Degrees

HWL Ebsworth acted for 1414 Degrees Ltd (ASX:14D), on its $16.3 million IPO and ASX listing, with trading of 14D shares commencing on 12 September 2018. Adelaide-based 1414 Degrees owns a patented Thermal Energy Storage System that utilises temperatures of up to 1414ºC and the latent heat properties of silicon to store and recover heat and … Read more


HWL Ebsworth advising Hong Kong Consortium led by Mason Group to acquire IVF provider Genea Limited by scheme of arrangement

HWL Ebsworth is advising the consortium led by Hong Kong listed Mason Group Holdings Limited, together with strategic investors, Aldworth Equity Management Limited, WeDoctor Holdings Limited (WeDoctor) on the proposed acquisition of 89.5% of Australia’s leading IVF provider, Genea Limited (Genea). Genea is Australia’s third-largest reproductive services provider. WeDoctor (which is backed by technology giant Tencent) is … Read more